Docebo (DCBO) Stock Forecast, Price Target & Predictions
DCBO Stock Forecast
Docebo stock forecast is as follows: an average price target of $51.75 (represents a 12.04% upside from DCBO’s last price of $46.19) and a rating consensus of 'Buy', based on 15 wall street analysts offering a 1-year stock forecast.
DCBO Price Target
The average price target for Docebo (DCBO) is $51.75 based on 1-year price targets from 15 Wall Street analysts in the past 3 months, with a price target range of $55.00 to $48.00. This represents a potential 12.04% upside from DCBO's last price of $46.19.
DCBO Analyst Ratings
According to 15 Wall Street analysts, Docebo's rating consensus is 'Buy'. The analyst rating breakdown for DCBO stock is 0 'Strong Buy' (0.00%), 12 'Buy' (80.00%), 3 'Hold' (20.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Docebo Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 24, 2024 | Kevin Krishnaratne | Scotiabank | $55.00 | $45.46 | 20.99% | 19.07% |
| Sep 16, 2024 | Kevin Kumar | Goldman Sachs | $48.00 | $42.47 | 13.02% | 3.92% |
| Sep 12, 2024 | Ryan MacDonald | Needham | $50.00 | $42.06 | 18.88% | 8.25% |
| Aug 09, 2024 | Robert Young | Canaccord Genuity | $54.00 | $41.74 | 29.37% | 16.91% |
| Jun 07, 2024 | George Sutton | Craig-Hallum | $58.00 | $37.22 | 55.83% | 25.57% |
| May 14, 2024 | Robert Young | Canaccord Genuity | $55.00 | $36.26 | 51.68% | 19.07% |
| May 14, 2024 | Kevin Krishnaratne | Scotiabank | $50.00 | $36.26 | 37.89% | 8.25% |
| Nov 14, 2023 | Ryan MacDonald | Needham | $56.00 | $51.22 | 9.33% | 21.24% |
| Aug 18, 2023 | Josh Baer | Morgan Stanley | $49.00 | $40.81 | 20.07% | 6.08% |
| Nov 11, 2022 | Morgan Stanley | $36.00 | $29.80 | 20.81% | -22.06% | |
| Apr 26, 2022 | Morgan Stanley | $54.00 | $46.07 | 17.21% | 16.91% | |
| Aug 13, 2021 | Brett Knoblauch | Cantor Fitzgerald | $82.00 | $71.87 | 14.09% | 77.53% |
The latest Docebo stock forecast, released on Oct 24, 2024 by Kevin Krishnaratne from Scotiabank, set a price target of $55.00, which represents a 20.99% increase from the stock price at the time of the forecast ($45.46), and a 19.07% increase from DCBO last price ($46.19).
Docebo Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 7 |
| Avg Price Target | - | $55.00 | $52.86 |
| Last Closing Price | $46.19 | $46.19 | $46.19 |
| Upside/Downside | -100.00% | 19.07% | 14.44% |
In the current month, the average price target of Docebo stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Docebo's last price of $46.19. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 24, 2024 | Scotiabank | Outperform | Outperform | Hold |
| Oct 24, 2024 | Scotiabank | Sector Outperform | Sector Outperform | Hold |
| Sep 16, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| Sep 12, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Sep 12, 2024 | Ascendiant | Buy | Buy | Hold |
| Sep 12, 2024 | BTIG | Buy | Buy | Hold |
| Sep 12, 2024 | Needham | Buy | Buy | Hold |
| Sep 12, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 09, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Jun 07, 2024 | Craig-Hallum | Buy | Initialise | |
| May 14, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| May 14, 2024 | Scotiabank | Sector Outperform | Sector Outperform | Hold |
| May 13, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Nov 14, 2023 | Needham | Buy | Initialise | |
| Aug 18, 2023 | Barclays | Equal-Weight | Downgrade | |
| Aug 18, 2023 | Benchmark | Buy | Upgrade | |
| Aug 18, 2023 | Argus Research | Buy | Upgrade | |
| Aug 18, 2023 | Zelman | Buy | Upgrade | |
| Aug 18, 2023 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| Aug 18, 2023 | Guggenheim | Buy | Upgrade | |
| Aug 18, 2023 | Edward Jones | Hold | Downgrade | |
| Nov 11, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Docebo's last stock rating was published by Scotiabank on Oct 24, 2024. The company gave DCBO a "Outperform" rating, the same as its previous rate.
Docebo Financial Forecast
Docebo Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $41.46M | $38.95M | $36.97M | $34.94M | $32.05M | $29.80M | $27.07M | - | - | $18.76M | $16.10M | - | - | $12.30M | $10.59M |
| Avg Forecast | $75.52M | $72.56M | $70.29M | $67.90M | $64.71M | $62.70M | $60.37M | $58.52M | $56.27M | $54.11M | $52.31M | $51.12M | $48.37M | $46.01M | $43.04M | $41.39M | $38.58M | $36.59M | $35.42M | $31.84M | $29.50M | $26.26M | $23.13M | $20.40M | $18.32M | $16.12M | $13.63M | $12.39M | $11.24M | $10.22M |
| High Forecast | $76.25M | $73.27M | $70.98M | $68.56M | $65.34M | $63.32M | $60.96M | $59.07M | $56.53M | $54.12M | $52.34M | $51.12M | $48.57M | $46.01M | $43.46M | $41.79M | $38.95M | $36.59M | $35.42M | $31.84M | $29.50M | $26.26M | $23.13M | $20.40M | $18.32M | $16.12M | $13.63M | $12.39M | $11.24M | $10.22M |
| Low Forecast | $74.75M | $71.82M | $69.58M | $67.21M | $64.05M | $62.07M | $59.76M | $58.07M | $56.14M | $54.10M | $52.29M | $51.12M | $48.17M | $46.01M | $42.60M | $40.97M | $38.19M | $36.59M | $35.42M | $31.84M | $29.50M | $26.26M | $23.13M | $20.40M | $18.32M | $16.12M | $13.63M | $12.39M | $11.24M | $10.22M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 8 | 4 | 4 | 5 | 7 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.01% | 0.99% | 1.01% | 1.01% | 1.03% | - | - | 1.02% | 1.00% | - | - | 1.09% | 1.04% |
Docebo's average Quarter revenue forecast for Jun 23 based on 3 analysts is $43.04M, with a low forecast of $42.60M, and a high forecast of $43.46M. DCBO's average Quarter revenue forecast represents a 3.80% increase compared to the company's last Quarter revenue of $41.46M (Mar 23).
Docebo EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 8 | 4 | 4 | 5 | 7 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.49M | $1.66M | $811.00K | $-1.70M | $-2.77M | $-2.23M | $2.06M | - | - | $-3.54M | $-330.00K | - | - | $-2.96M | $-2.86M |
| Avg Forecast | $-5.00M | $-4.80M | $-4.65M | $-4.50M | $-4.28M | $-4.15M | $-4.00M | $-3.87M | $-3.73M | $-3.58M | $-3.46M | $-3.38M | $-3.20M | $-3.05M | $-2.85M | $-2.74M | $-2.55M | $-3.10M | $-3.00M | $-2.70M | $-2.50M | $4.45M | $-1.96M | $-1.73M | $-1.55M | $-1.37M | $-1.16M | $-1.05M | $-953.15K | $-866.45K |
| High Forecast | $-4.95M | $-4.76M | $-4.61M | $-4.45M | $-4.24M | $-4.11M | $-3.96M | $-3.84M | $-3.72M | $-3.58M | $-3.46M | $-3.38M | $-3.19M | $-3.05M | $-2.82M | $-2.71M | $-2.53M | $-3.10M | $-3.00M | $-2.70M | $-2.50M | $5.34M | $-1.96M | $-1.73M | $-1.55M | $-1.37M | $-1.16M | $-1.05M | $-953.15K | $-866.45K |
| Low Forecast | $-5.05M | $-4.85M | $-4.70M | $-4.54M | $-4.33M | $-4.19M | $-4.04M | $-3.91M | $-3.74M | $-3.58M | $-3.47M | $-3.38M | $-3.22M | $-3.05M | $-2.88M | $-2.77M | $-2.58M | $-3.10M | $-3.00M | $-2.70M | $-2.50M | $3.56M | $-1.96M | $-1.73M | $-1.55M | $-1.37M | $-1.16M | $-1.05M | $-953.15K | $-866.45K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.91% | -0.65% | -0.26% | 0.56% | 1.02% | 0.89% | 0.46% | - | - | 2.28% | 0.24% | - | - | 3.10% | 3.30% |
3 analysts predict DCBO's average Quarter EBITDA for Jun 23 to be $-2.85M, with a high of $-2.82M and a low of $-2.88M. This is -214.34% lower than Docebo's previous annual EBITDA (Mar 23) of $2.49M.
Docebo Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 8 | 4 | 4 | 5 | 7 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.25M | $1.60M | $10.27M | $2.10M | $-6.96M | $-1.43M | $661.00K | - | - | $-3.74M | $-1.16M | - | - | $-3.30M | $-3.74M |
| Avg Forecast | $10.21M | $9.59M | $9.28M | $8.66M | $10.62M | $10.01M | $8.87M | $8.18M | $8.32M | $7.12M | $6.63M | $5.17M | $3.83M | $2.40M | $1.62M | $994.26K | $374.16K | $-955.69K | $-1.08M | $-1.93M | $-2.15M | $1.43M | $-2.54M | $-1.71M | $-664.89K | $-2.11M | $-2.38M | $-1.55M | $-1.09M | $-2.80M |
| High Forecast | $10.34M | $9.71M | $9.40M | $8.77M | $10.76M | $10.14M | $8.99M | $8.28M | $8.43M | $7.15M | $6.83M | $5.23M | $3.88M | $2.43M | $1.64M | $1.01M | $378.92K | $-955.69K | $-1.08M | $-1.93M | $-2.15M | $1.71M | $-2.54M | $-1.71M | $-664.89K | $-2.11M | $-2.38M | $-1.55M | $-1.09M | $-2.80M |
| Low Forecast | $10.08M | $9.46M | $9.16M | $8.55M | $10.48M | $9.88M | $8.75M | $8.07M | $8.21M | $7.09M | $6.44M | $5.10M | $3.60M | $2.37M | $1.59M | $981.14K | $369.22K | $-955.69K | $-1.08M | $-1.93M | $-2.15M | $1.14M | $-2.54M | $-1.71M | $-664.89K | $-2.11M | $-2.38M | $-1.55M | $-1.09M | $-2.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.25% | 4.28% | -10.75% | -1.94% | 3.61% | 0.66% | 0.46% | - | - | 5.63% | 0.55% | - | - | 3.03% | 1.34% |
Docebo's average Quarter net income forecast for Jun 23 is $1.62M, with a range of $1.59M to $1.64M. DCBO's average Quarter net income forecast represents a 29.78% increase compared to the company's last Quarter net income of $1.25M (Mar 23).
Docebo SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 8 | 4 | 4 | 5 | 7 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $25.59M | $23.98M | $24.35M | $24.01M | $22.22M | $20.50M | $18.70M | - | - | $12.50M | $9.88M | - | - | $9.39M | $9.26M |
| Avg Forecast | $51.85M | $49.82M | $48.26M | $46.62M | $44.43M | $43.05M | $41.45M | $40.18M | $38.63M | $37.15M | $35.92M | $35.10M | $33.21M | $31.59M | $29.55M | $28.41M | $26.49M | $25.12M | $24.32M | $21.86M | $20.26M | $18.03M | $15.88M | $14.01M | $12.58M | $11.07M | $9.36M | $8.51M | $7.72M | $7.01M |
| High Forecast | $52.35M | $50.30M | $48.73M | $47.07M | $44.86M | $43.47M | $41.85M | $40.56M | $38.82M | $37.16M | $35.93M | $35.10M | $33.34M | $31.59M | $29.84M | $28.69M | $26.75M | $25.12M | $24.32M | $21.86M | $20.26M | $18.03M | $15.88M | $14.01M | $12.58M | $11.07M | $9.36M | $8.51M | $7.72M | $7.01M |
| Low Forecast | $51.32M | $49.31M | $47.77M | $46.15M | $43.98M | $42.61M | $41.03M | $39.87M | $38.54M | $37.15M | $35.90M | $35.10M | $33.07M | $31.59M | $29.25M | $28.13M | $26.22M | $25.12M | $24.32M | $21.86M | $20.26M | $18.03M | $15.88M | $14.01M | $12.58M | $11.07M | $9.36M | $8.51M | $7.72M | $7.01M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.91% | 0.97% | 0.99% | 1.02% | 1.01% | 1.04% | - | - | 0.99% | 0.89% | - | - | 1.22% | 1.32% |
Docebo's average Quarter SG&A projection for Jun 23 is $29.55M, based on 3 Wall Street analysts, with a range of $29.25M to $29.84M. The forecast indicates a 15.44% rise compared to DCBO last annual SG&A of $25.59M (Mar 23).
Docebo EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 8 | 4 | 4 | 5 | 7 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.04 | $0.05 | $0.31 | $0.06 | $-0.21 | $-0.04 | $0.02 | - | - | $-0.13 | $-0.04 | - | - | $-0.12 | $-0.13 |
| Avg Forecast | $0.33 | $0.31 | $0.30 | $0.28 | $0.34 | $0.32 | $0.29 | $0.26 | $0.27 | $0.23 | $0.21 | $0.17 | $0.12 | $0.08 | $0.05 | $0.03 | $0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.07 | $-0.07 | $-0.08 | $-0.06 | $-0.02 | $-0.07 | $-0.08 | $-0.05 | $-0.04 | $-0.09 |
| High Forecast | $0.33 | $0.31 | $0.30 | $0.28 | $0.35 | $0.33 | $0.29 | $0.27 | $0.27 | $0.23 | $0.22 | $0.17 | $0.13 | $0.08 | $0.05 | $0.03 | $0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.07 | $-0.07 | $-0.08 | $-0.06 | $-0.02 | $-0.07 | $-0.08 | $-0.05 | $-0.04 | $-0.09 |
| Low Forecast | $0.33 | $0.31 | $0.30 | $0.28 | $0.34 | $0.32 | $0.28 | $0.26 | $0.27 | $0.23 | $0.21 | $0.16 | $0.12 | $0.08 | $0.05 | $0.03 | $0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.07 | $-0.07 | $-0.08 | $-0.06 | $-0.02 | $-0.07 | $-0.08 | $-0.05 | $-0.04 | $-0.09 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.24% | 4.13% | -10.07% | -1.72% | 3.39% | 0.63% | -0.28% | - | - | 6.08% | 0.59% | - | - | 3.31% | 1.46% |
According to 3 Wall Street analysts, Docebo's projected average Quarter EPS for Jun 23 is $0.05, with a low estimate of $0.05 and a high estimate of $0.05. This represents a 30.55% increase compared to DCBO previous annual EPS of $0.04 (Mar 23).
Docebo Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| JAMF | Jamf | $15.05 | $22.40 | 48.84% | Buy |
| ALKT | Alkami | $39.10 | $45.67 | 16.80% | Buy |
| SSNC | SS&C Technologies | $76.03 | $83.50 | 9.83% | Buy |
| DSGX | Descartes Systems Group | $119.25 | $128.60 | 7.84% | Buy |
| CWAN | Clearwater Analytics | $29.55 | $31.33 | 6.02% | Buy |
| ANSS | ANSYS | $343.07 | $359.60 | 4.82% | Buy |
| DCBO | Docebo | $49.57 | $51.75 | 4.40% | Buy |
| MANH | Manhattan Associates | $295.06 | $297.67 | 0.88% | Buy |
| ALRM | Alarm.com | $67.86 | $66.00 | -2.74% | Buy |
| DDOG | Datadog | $156.91 | $148.25 | -5.52% | Buy |
| PCOR | Procore | $79.43 | $75.00 | -5.58% | Buy |
| TTD | Trade Desk | $135.02 | $123.63 | -8.44% | Buy |
| PYCR | Paycor HCM | $20.16 | $18.25 | -9.47% | Hold |
| HUBS | HubSpot | $741.67 | $671.25 | -9.49% | Buy |
| NOW | ServiceNow | $1.11K | $973.56 | -12.66% | Buy |
| U | Unity Software | $24.66 | $21.33 | -13.50% | Hold |
| TEAM | Atlassian | $269.79 | $231.46 | -14.21% | Buy |
| SHOP | Shopify | $119.49 | $98.43 | -17.62% | Buy |
| FSLY | Fastly | $11.33 | $6.75 | -40.42% | Hold |
| ASAN | Asana | $26.32 | $14.00 | -46.81% | Buy |